NCT00054327 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Patients receive cytarabine 3.0gm/M² IV over 1 hour twice daily on days -9 to -7 and cyclophosphamide 45mg/kg IV over 2 hours on days -6 and -5. Patients also undergo total body irradiation (TBI), 165 cGY, twice daily on days -4 to -1 for a total of 1320 cGY.
- id
- FG000
- title
- Regimen A
- description
- Patients receive cyclophosphamide 60 mg/kg IV on days -6 and -5. Patients also undergo total body irradiation (TBI) twice daily on days -4 to -1 for a total of 1320 cGY..
- id
- FG001
- title
- Regimen B-1
- description
- Patients receive cyclophosphamide 60 mg/kg IV over 2 hours on days -5 and -4. Patients also undergo TBI twice daily on days -3 to -1 for a total of 1200 cGY.
- id
- FG002
- title
- Regimen B-2
- description
- Patients undergo total body irradiation (TBI) twice daily on days -7 to -5 for a total of 1200 cGY. Patients then receive cyclophosphamide 60 mg/kg IV on days -4 and -3.
- id
- FG003
- title
- Regimen B-3
- description
- Patients receive oral busulfan 1mg/kg/dose (or 40mg/m2/dose for young children)4 times daily on days -8 to -5 and cyclophosphamide 60 mg/kg IV over 2 hours on days -4 to -2.
- id
- FG004
- title
- Regimen C
- description
- Patients receive total body irradiation (TBI) on days T -6, -5 and -4 for a total of 1320 cGy , then etoposide (60mg/kg/dose) on day -3.
- id
- FG005
- title
- Regimen D
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- Engraftment failure
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 2
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 10
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 2
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Thirty-five patients were recruited from local medical clinic from November 2000 through November 2009.One patient relapsed and never received a transplant.
Complete source fields
- groups
- description
- Patients receive cytarabine 3.0gm/M² IV over 1 hour twice daily on days -9 to -7 and cyclophosphamide 45mg/kg IV over 2 hours on days -6 and -5. Patients also undergo total body irradiation (TBI), 165 cGY, twice daily on days -4 to -1 for a total of 1320 cGY.
- id
- FG000
- title
- Regimen A
- description
- Patients receive cyclophosphamide 60 mg/kg IV on days -6 and -5. Patients also undergo total body irradiation (TBI) twice daily on days -4 to -1 for a total of 1320 cGY..
- id
- FG001
- title
- Regimen B-1
- description
- Patients receive cyclophosphamide 60 mg/kg IV over 2 hours on days -5 and -4. Patients also undergo TBI twice daily on days -3 to -1 for a total of 1200 cGY.
- id
- FG002
- title
- Regimen B-2
- description
- Patients undergo total body irradiation (TBI) twice daily on days -7 to -5 for a total of 1200 cGY. Patients then receive cyclophosphamide 60 mg/kg IV on days -4 and -3.
- id
- FG003
- title
- Regimen B-3
- description
- Patients receive oral busulfan 1mg/kg/dose (or 40mg/m2/dose for young children)4 times daily on days -8 to -5 and cyclophosphamide 60 mg/kg IV over 2 hours on days -4 to -2.
- id
- FG004
- title
- Regimen C
- description
- Patients receive total body irradiation (TBI) on days T -6, -5 and -4 for a total of 1320 cGy , then etoposide (60mg/kg/dose) on day -3.
- id
- FG005
- title
- Regimen D
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- Engraftment failure
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 2
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 10
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 2
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- Thirty-five patients were recruited from local medical clinic from November 2000 through November 2009.One patient relapsed and never received a transplant.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle